右美托咪啶辅助椎管内麻醉的镇静效果分析

《右美托咪啶辅助椎管内麻醉的镇静效果分析》由会员上传分享，免费在线阅读，更多相关内容在工程资料-天天文库。

1、右美托咪噪辅助椎管内麻醉的镇静效果分析焦艳玲赵俊锦岳永猛陈力(巴中市中心医院麻醉科四川巴中636000)【摘要】目的：分析右美托咪噪辅助椎管内麻醉的镇静效果。方法：选取木院2013年10月〜2014年10月收治的行椎管内麻醉择期手术的患者60例为研究对象，将其随机分为对照组与观察组，每组各30例。所有患者均行椎管内麻醉，麻醉起效以后，观察组依剂量为0.5mg/kg施以4mg/ml右美托咪唳行静脉泵注lOmin,维持以0.1〜0.3mg/kg,对照组采取与观察组同样的方式行静脉泵注牛理盐水，观察患者麻醉前、开始手术时、内脏牵拉时、腹膜牵拉时、手术完成时这几个时间点的Rams

2、ay镇静评分和患者不良反应发牛情况。结果：对比两组患者开始手术时、内脏牵拉时、腹膜牵拉时、手术完成时的Ramsay评分,差异有统计学意义(PV0.05)；对比两组患者不良反应发生情况，差异显著，有统计学意义(χ2=18.8236,P<0.05)o结论：右美托咪噪辅助椎管内麻醉镇静效果较好，对患者的呼吸抑制较轻，H能保持较好的镇静状态，明显减少不良反应，右美托咪噪是辅助镇静用药的理想选择，具有临床推广价值。【关键词】右美托咪噪；椎管内麻醉；镇静【中图分类号】R614【文献标识码】A【文章编号】2095-1752(2016)05-0041-02Analysisofde

3、xmedetomidineassistedspinalanesthesiasedationJiaoYanling,ZhaoJunjin,YueYongmeng,ChenLi.TheCentralHospitalofBazhongCity,Sichuan,Bazhong636000,China【Abstract]ObjectiveToanalyzetheeffectsofdexmedetomidineassistedspinalanesthesiasedation.Methods60casesofpatientsundergoingelectivesurgeryinourh

4、ospitalfromOctober2013toOctober2014wererandomlydividedintocontrolgroupandobservationgroup,30casesineachgroup.Allpatientsunderwentspinalanesthesia,aftertheonsetofanesthesia,theobservationgroupaccordingtothedoseis0.5g/kgimpose4G/mlrightdexmedetomidineveininfusion10min,maintainto0.1~0.3g/kg,

5、wereadoptedinthecontrolgroupandobservationgroupthesamewayintravenousinfusionofnormalsaline,observationofpatientsbeforeanesthesia,beginningofoperation,visceralandperitonealtraction,theoperationhasbeencompletedthispointintimeafewoftheRamsaySedationscoreandadversereactionsinpatientswith・Resu

6、ltsComparingthetwogroupsofpatientstostarttheoperation,visceraltraction,peritonealtraction,whenthesurgeryiscompletetheRamsayscore,thediffereneeisstatisticallysign讦icant(P<0.05),comparedtwogroupsofpatientswithadversereactionsoccur,significantdifferencesandstatisticalsignificance(χ2=1

7、8.8236it,(P<0.05).ConclusionDexmedetomidineassistedintraspinalanesthesiasedationeffectbetter,thepatient'srespiratoryinhibitionislighter,andcankeepgoodsedation,significantlyreduceadversereactions,dexmedetomidineisidealsedationmedicationofchoice,whichisworthyofclin